港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

生物醫藥B類股

801.662

-11.423-1.40%

漲家數：10

跌家數：23

平家數：1

市盈率：- -

高：825.541

開：813.411

低：798.667

收：813.086

成交量：1.40億

成交額：38.52億

市值：4,807.11億

流通市值：4,368.04億

資料載入中...

創新藥板塊午後持續走低，苑東生物跌超8%

齊魯製藥（海南）有限公司申請II類會議

港股異動 | 榮昌生物(09995.HK)再漲超4% 公司上半年減虧顯著機構看好其長期發展潛力

港股異動 | 歌禮制藥-B(01672.HK)早盤漲超5% 公司配股加碼減肥藥研發花旗建議關注即將發佈的ASC30二期數據

諾誠健華(09969)出現大手買入29.5萬股，成交價$17.6，涉資519.2萬

阿斯达克财经

大行評級｜花旗：上調榮昌生物目標價至35港元仍維持“沽售/高風險”評級

貝康醫療Gems培養液獲註冊證，開啓國產化新篇章

創新藥概念部分逆市上揚康諾亞-B(02162)漲超3% 機構看好2025年研發催化與集採出清機遇

“藥神”照進現實：中國原創抗癌藥榮獲上海市科技進步一等獎

榮昌生物(09995.HK)曾漲逾8% 上半年收入增近五成兼虧損收窄

阿斯达克财经

醫療器械板塊拐點或至，資金左側大舉增倉，醫療器械指數ETF（159898）近10日獲近1.2億元資金埋伏

港股異動｜$生物(000504)$醫藥股逆勢走高，$永泰生物-B(06978)$漲超5%，$加科思-B(01167)$、

老虎资讯综合

美藍醫藥申請一種安瓿瓶的激光切割裝置專利，便於將安瓿瓶本體輸送至切割頭處進行切割

國產創新藥靠BD大火醫療器械能否複製這一路徑？

8月26日再鼎醫藥在港交所公告上半年產品收入淨額同比增加15%至2.15億美元；研發開支同比減少4%至1.11億美元；虧

中藥上市公司半年報紛紛提及加大創新藥研發

再鼎醫藥(09688)發佈中期業績，總收入2.16億美元同比增加15.35%

醫藥板塊下跌特朗普再放狠話：下調藥品價格1400%至1500%

華麗家族股價持平 3億元增資創新藥企引關注

一心堂股價持平醫藥商業板塊成交額達2.66億元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1574/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物醫藥B類股","latestPrice":801.6624,"timestamp":1756187003000,"preClose":813.08563,"halted":0,"volume":139853045,"delay":0,"changeRate":-0.014049,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-11.423218,"latestTime":"08-26 13:43:24","open":813.4112,"high":825.54065,"low":798.6673,"amount":3851826236,"amplitude":0.033051,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1756195800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"pbRate":6.722096,"peRate":-40.784235,"turnoverRate":0.005231,"increases":10,"decrements":23,"flats":0,"marketCap":480710783360,"floatMarketCap":436803733408},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":825.54065,"amplitude":0.033051,"preClose":813.08563,"low":798.6673,"pbRate":"6.722096","latestPrice":801.6624,"volume":139853045,"delay":0,"open":813.4112,"prevYearClose":331.1933,"prevWeekClose":829.54,"prevMonthClose":735.033,"prevQuarterClose":555.617,"fiveDayClose":830.772,"twentyDayClose":768.836,"sixtyDayClose":474.737,"secType":"PLATE","market":"HK","turnoverRate":0.005231,"peRate":-40.784235,"marketCap":480710783360,"floatMarketCap":436803733408,"timestamp":1756187003000,"nameCN":"生物醫藥B類股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":10,"down":23,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2562745201","title":"創新藥板塊午後持續走低，苑東生物跌超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562745201","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562745201?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 13:24","pubTimestamp":1756185869,"startTime":"0","endTime":"0","summary":"创新药板块午后持续走低，苑东生物跌超8%，申联生物、热景生物跌超6%，广生堂、凯莱英、立方制药跌超5%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/26132452692431.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK1574","06978","BK1161","159992","688513"],"gpt_icon":0},{"id":"2562209282","title":"齊魯製藥（海南）有限公司申請II類會議","url":"https://stock-news.laohu8.com/highlight/detail?id=2562209282","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562209282?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 12:35","pubTimestamp":1756182905,"startTime":"0","endTime":"0","summary":"金融界8月26日消息，据CDE官网沟通交流公示，于8月26日收到齐鲁制药 有限公司申请的“II类会议”，当前状态“处理中”。齐鲁制药（海南）有限公司，成立于2005年，位于海口市，是一家以从事医药制造业为主的企业。通过天眼查大数据分析，齐鲁制药（海南）有限公司共对外投资了1家企业，参与招投标项目5000次，专利信息96条，此外企业还拥有行政许可945个。主要股东信息显示，齐鲁制药（海南）有限公司由齐鲁制药集团有限公司持股100%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/26123552691489.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","01477","BK1191"],"gpt_icon":0},{"id":"2562203156","title":"港股異動 | 榮昌生物(09995.HK)再漲超4% 公司上半年減虧顯著 機構看好其長期發展潛力","url":"https://stock-news.laohu8.com/highlight/detail?id=2562203156","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562203156?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 10:58","pubTimestamp":1756177122,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09995","688331","LU2328871848.SGD","BK1574","BK1583","LU2488822045.USD","LU2148510915.USD","LU1969619763.USD","LU1064130708.USD","BK0239","BK1161","LU1064131003.USD"],"gpt_icon":0},{"id":"2562203802","title":"港股異動 | 歌禮制藥-B(01672.HK)早盤漲超5% 公司配股加碼減肥藥研發 花旗建議關注即將發佈的ASC30二期數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2562203802","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562203802?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 10:48","pubTimestamp":1756176529,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0648001328.SGD","LU0477156953.USD","LU0106831901.USD","LU2360032135.SGD","LU1244550494.USD","LU0098860793.USD","LU0170899867.USD","LU1366192091.USD","BK1515","LU0052756011.USD","LU1791807156.HKD","LU0130517989.USD","LU0980610538.SGD","BK4534","LU0162691827.USD","01477","LU2236285917.USD","LU0128525689.USD","LU0310800965.SGD","BK1191","LU1162221912.USD","LU1244550577.SGD","LU2417539215.USD","IE00BSNM7G36.USD","LU0320765646.SGD","BK4207","BK1161","LU1668664300.SGD","BK4559","LU2125154935.USD","LU0130102774.USD","LU1267930227.SGD","BK4566","BK1574","BK4585","LU2462157665.USD","BK4588","BK4504","01672","LU1244550221.USD","LU1201861249.SGD","LU2125154778.USD","LU0072461881.USD","LU2456880835.USD"],"gpt_icon":0},{"id":"2562020331","title":"諾誠健華(09969)出現大手買入29.5萬股，成交價$17.6，涉資519.2萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2562020331","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562020331?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 10:39","pubTimestamp":1756175940,"startTime":"0","endTime":"0","summary":"[大手成交]诺诚健华(09969)在上午10:39出现大手买入，成交量为29.5万，成交价为港币$17.6，涉资519.2万。至目前为止，股价跌2.331%，今日最高价为$18.48，而最低价为$17.6，总成交量为630.215万股，总成交金额港币$1.139亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150431576_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150431576_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2508264854/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","BK0239","BK1574","09969","688428"],"gpt_icon":0},{"id":"2562208493","title":"大行評級｜花旗：上調榮昌生物目標價至35港元 仍維持“沽售/高風險”評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2562208493","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562208493?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 10:37","pubTimestamp":1756175866,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0052756011.USD","688331","LU1244550221.USD","LU2488822045.USD","LU0310800965.SGD","LU1201861249.SGD","LU0320765646.SGD","BK4504","LU2125154778.USD","BK1161","LU1969619763.USD","LU2148510915.USD","LU0130102774.USD","LU2462157665.USD","LU2360032135.SGD","LU0170899867.USD","BK4585","LU1791807156.HKD","LU0162691827.USD","LU0980610538.SGD","LU2417539215.USD","LU0072461881.USD","LU0477156953.USD","LU0130517989.USD","BK1583","09995","LU2236285917.USD","LU2125154935.USD","LU0098860793.USD","BK0239","LU0128525689.USD","BK4207","BK4534","LU1366192091.USD","LU0648001328.SGD","LU1064131003.USD","BK4559","IE00BSNM7G36.USD","LU1064130708.USD","LU1267930227.SGD","BK4566","LU1244550577.SGD","LU1162221912.USD","LU2328871848.SGD","LU1244550494.USD","LU0106831901.USD","BK1574","BK4588","LU2456880835.USD","LU1668664300.SGD"],"gpt_icon":0},{"id":"2562089522","title":"貝康醫療Gems培養液獲註冊證，開啓國產化新篇章","url":"https://stock-news.laohu8.com/highlight/detail?id=2562089522","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562089522?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 10:27","pubTimestamp":1756175262,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["S68.SI","SGXZ58947870.SGD","TGA","SG9999000343.SGD","FESXmain","LU0192582467.USD","LU2401740654.USD","SG9999013478.USD","LU2242652126.USD","SG9999003826.SGD","SG9999006266.SGD","LU0326948709.USD","LU0831103253.SGD","SGXZ27511609.SGD","SG9999004360.SGD","BK1222","SG9999001846.SGD","FSTM.SI","SG9999014484.SGD","SG9999013460.SGD","LU0898667661.SGD","BK1574","BK6033","BK6523","CE","BK4213","LU2242646821.SGD","SG9999001135.SGD","BK6516","LU2242646235.USD","BK4109","LU0877626530.USD","BK4588","STI.SI","LU1119993845.HKD","ES3.SI","02170","LU1920062954.HKD","SG9999013486.USD","BK4585","BK1597","FSTAS.SI","LU0205439572.USD","LU0188438112.USD","SG9999016042.SGD","FSXEmain","LU1920063259.USD","SG9999014492.USD"],"gpt_icon":0},{"id":"2562270073","title":"創新藥概念部分逆市上揚 康諾亞-B(02162)漲超3% 機構看好2025年研發催化與集採出清機遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2562270073","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562270073?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 10:03","pubTimestamp":1756173802,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念部分逆市上扬，康诺亚-B 涨3.02%，云顶新耀涨2.97%，欧康维视生物-B涨2.29%，博安生物涨2.50%，巨子生物涨2.39%，同源康医药-B涨1.98%，歌礼制药-B涨2.24%，科伦博泰生物-B涨1.32%，翰森制药涨1.33%。国元证券指出，目前中报已经临近尾声，市场也将逐步的从关注中报业绩转移到新的方向，2025年下半年继续看好创新药、出海以及集采出清板块。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1964821","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004311.SGD","BK1515","BK1574","LU2488822045.USD","BK1191","159992","03692","06990","LU0196878994.USD","02410","02162","BK1583","01477","BK1161","02367","BK1587","06978","BK1589","01672","01952","06955","BK1207"],"gpt_icon":0},{"id":"2562075270","title":"“藥神”照進現實：中國原創抗癌藥榮獲上海市科技進步一等獎","url":"https://stock-news.laohu8.com/highlight/detail?id=2562075270","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562075270?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 09:58","pubTimestamp":1756173532,"startTime":"0","endTime":"0","summary":"【“药神”照进现实：中国原创抗癌药荣获上海市科技进步一等奖】还记得电影《我不是药神》中天价抗癌药的困境吗？中国科学家用一场历时11年的“破冰之旅”，交出了一份现实版答卷——中国首个自主研发的高选择性抗癌药呋喹替尼，不仅让晚期结直肠癌患者生存期显著延长，更成功打入欧美日主流市场，成为全球抗癌药领域的“新标杆”。今天，这一由和记黄埔医药（上海）有限公司领衔的研发项目荣获上海市科技进步奖一等奖，标志着中国创新药从“跟跑”到“领跑”的历史性跨越。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202508263494600446.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","BK1574","BK1588","00013","BK1161","06978","BK1587"],"gpt_icon":0},{"id":"2562827016","title":"榮昌生物(09995.HK)曾漲逾8% 上半年收入增近五成兼虧損收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2562827016","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562827016?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 09:47","pubTimestamp":1756172820,"startTime":"0","endTime":"0","summary":"荣昌生物(09995.HK) 今日(26日)高开0.9%，早段曾升8.6%高见96.35元。现报94.5元，升6.54%，成交381.27万股，涉资3.56亿元。公司日前公布业绩，收益录得10.9亿人民币(下同)，按年增加47.6%，主要是公司自身免疫类商业化产品泰它西普以及抗肿瘤类商业化产品维迪西妥单抗销售增长强劲；亏损由上年同期7.8亿元，收窄至4.5亿元。不派息。(ss/)(港股报价延迟最少十五分钟。沽空资料截至 2025-08-25 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210305144101571_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210305144101571_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1464324/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK0239","688331","BK1583","LU2148510915.USD","09995","LU2328871848.SGD","LU2488822045.USD","BK1161","LU1064131003.USD","LU1969619763.USD","LU1064130708.USD"],"gpt_icon":0},{"id":"2562277034","title":"醫療器械板塊拐點或至，資金左側大舉增倉，醫療器械指數ETF（159898）近10日獲近1.2億元資金埋伏","url":"https://stock-news.laohu8.com/highlight/detail?id=2562277034","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562277034?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 09:40","pubTimestamp":1756172413,"startTime":"0","endTime":"0","summary":"近期A股情绪高涨，上证指数连破3700、3800两道大关，成交额连续多日超2万亿元。根据深交所数据，医疗器械指数ETF已经连续10日获1.16亿元资金增仓，近20日这一数据为1.63亿元。基金最新规模4.1亿元刷新上市新高。不过从价格角度看，该ETF昨日收盘价0.616元，自2021年上市以来回撤幅度依然为四成。从基金多个阶段表现看，医疗器械指数ETF今年以来、近一年、近三年均跑赢业绩比较基准，超额能力居同指数ETF前列。","market":"hk","thumbnail":"https://imgcloud.jrjimg.cn/2025/08/20250826093933020.jpg","type":0,"news_type":0,"thumbnails":["https://imgcloud.jrjimg.cn/2025/08/20250826093933020.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.jrj.com.cn/2025/08/26094052686268.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["09997","BK4550","BK1583","BK1574","BK4585","BK4588","09996","159898","BK1222","159883","BK1100","FDN"],"gpt_icon":0},{"id":"1139693123","title":"港股異動｜$生物(000504)$醫藥股逆勢走高，$永泰生物-B(06978)$漲超5%，$加科思-B(01167)$、","url":"https://stock-news.laohu8.com/highlight/detail?id=1139693123","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139693123?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 09:36","pubTimestamp":1756172181,"startTime":"0","endTime":"0","summary":"港股异动｜$生物(000504)$医药股逆势走高，$永泰生物-B(06978)$涨超5%，$加科思-B(01167)$、$荣昌生物(09995)$涨超4%，$歌礼制药-B(01672)$涨超2%.","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSTECH","09939","01672","09995","LU2328871848.SGD","BK1515","BK4614","LU1969619763.USD","01167","YANG","BK1583","BK1574","01477","BK1161","07226","06978","HSCEI","BK1191"],"gpt_icon":0},{"id":"2562927212","title":"美藍醫藥申請一種安瓿瓶的激光切割裝置專利，便於將安瓿瓶本體輸送至切割頭處進行切割","url":"https://stock-news.laohu8.com/highlight/detail?id=2562927212","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562927212?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 09:06","pubTimestamp":1756170381,"startTime":"0","endTime":"0","summary":"金融界2025年8月26日消息，国家知识产权局信息显示，美蓝 医药科技有限公司申请一项名为“一种安瓿瓶的激光切割装置”的专利，公开号CN120533315A，申请日期为2025年06月。通过天眼查大数据分析，美蓝（杭州）医药科技有限公司共对外投资了8家企业，财产线索方面有商标信息4条，专利信息136条，此外企业还拥有行政许可7个。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/26090652685205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1515","BK1161","BK1574","159938","09939"],"gpt_icon":0},{"id":"2562027949","title":"國產創新藥靠BD大火 醫療器械能否複製這一路徑？","url":"https://stock-news.laohu8.com/highlight/detail?id=2562027949","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562027949?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 07:52","pubTimestamp":1756165922,"startTime":"0","endTime":"0","summary":"【国产创新药靠BD大火 医疗器械能否复制这一路径？】“BD（业务发展）是个大热点，我们最近的一次线上会起码有一半时间，分析师都在问相关话题。”近期，一位国内医疗器械行业人士向澎湃新闻记者发出了这样的感慨。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202508263494220491.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202508263494220491.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06978","BK1100","BK1222","BK1574","BK1161","09997","09996","BK1583"],"gpt_icon":0},{"id":"2562276974","title":"8月26日再鼎醫藥在港交所公告上半年產品收入淨額同比增加15%至2.15億美元；研發開支同比減少4%至1.11億美元；虧","url":"https://stock-news.laohu8.com/highlight/detail?id=2562276974","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562276974?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 07:09","pubTimestamp":1756163380,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09688","BK1574","BK4139","BK1588","HEXmain","BK4526","BK4585","BK4531","BK4588","BK1161","BK4548","ZLAB","LU2488822045.USD"],"gpt_icon":0},{"id":"2562764812","title":"中藥上市公司半年報紛紛提及加大創新藥研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2562764812","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562764812?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 07:09","pubTimestamp":1756163340,"startTime":"0","endTime":"0","summary":"　　同花顺数据显示，截至8月25日，共计27家中药上市公司发布2025年半年度业绩报告。其中，10家上半年营业收入实现正增长，增幅超10%的有6家；13家归属于上市公司股东的净利润实现正增长，占比约48%。　　当前，我国医药行业正处于从传统医药向创新医药转型的关键发展阶段。　　从已披露的半年报看，上半年中药上市公司经营“喜忧参半”，业绩分化明显。　　加大创新药研发也是中药上市公司在半年报中频频提及的重要战略。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hyyj/2025-08-26/doc-infnhekr6991554.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","BK1574","159992","06978"],"gpt_icon":0},{"id":"2562276863","title":"再鼎醫藥(09688)發佈中期業績，總收入2.16億美元 同比增加15.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562276863","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562276863?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 06:45","pubTimestamp":1756161948,"startTime":"0","endTime":"0","summary":"智通财经APP讯，再鼎医药(09688)发布2025年中期业绩，该集团取得总收入2.16亿美元，同比增加15.35%;亏损净额8916.5万美元，同比减少33.33%;每股亏损0.08美元。产品收入净额增加2750万美元(或15%)至2.15亿美元，主要由于卫伟迦的销售额受疗程延长及市场渗透率提升的推动而增长、纽再乐的销售额受市场覆盖范围及渗透率提升的推动而增长及自2024年第四季度起上市的鼎优乐的销售额增长。研发开支减少490万美元(或4%)至1.11亿美元，主要由于持续的资源优化及效率提升令人员和临床试验成本减少，部分被许可费增加所抵销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1334991.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"再鼎医药(09688)发布中期业绩，总收入2.16亿美元 同比增加15.35%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK4531","BK4548","BK4585","LU2488822045.USD","BK1588","09688","BK4139","BK1574","BK4526","BK4588","ZLAB"],"gpt_icon":0},{"id":"2562275654","title":"醫藥板塊下跌 特朗普再放狠話：下調藥品價格1400%至1500%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562275654","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562275654?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 06:00","pubTimestamp":1756159200,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09939","159938","BK1574","BK1161","BK1515"],"gpt_icon":0},{"id":"2562221405","title":"華麗家族股價持平 3億元增資創新藥企引關注","url":"https://stock-news.laohu8.com/highlight/detail?id=2562221405","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562221405?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 01:49","pubTimestamp":1756144177,"startTime":"0","endTime":"0","summary":"截至8月25日收盘，华丽家族股价报3.15元，与前一交易日持平。当日成交额达4.84亿元，换手率为9.61%。华丽家族主营业务为房地产开发，同时涉及石墨烯等新材料领域。近期公司公告拟以不超过3亿元现金认购海和药物5%-8.09%股份，跨界布局创新药领域。8月10日公司公告显示，此次投资标的海和药物已有3款创新药上市，包括治疗非小细胞肺癌的谷美替尼片等产品。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/26014952680099.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","BK0077","600503","159992","BK0188","BK0273","BK0061","BK0028","BK0012","06978","BK1574","BK0131"],"gpt_icon":0},{"id":"2562229205","title":"一心堂股價持平 醫藥商業板塊成交額達2.66億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562229205","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562229205?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 01:19","pubTimestamp":1756142343,"startTime":"0","endTime":"0","summary":"截至2025年8月25日收盘，一心堂股价报15.16元，与前一交易日持平。当日成交量为176026手，成交金额2.66亿元，换手率为4.43%。一心堂属于医药商业板块，同时涉及云南板块、内贸流通等概念。公司主要从事医药零售连锁和医药批发业务，在云南省内具有较高的市场占有率。8月25日主力资金净流出2656.6万元，占流通市值的0.44%。近五个交易日累计净流出4280.52万元，占流通市值的0.71%。风险提示：股市有风险，投资需谨慎。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/26011952680008.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1515","BK1161","002727","09939","159938","BK0209","BK0097","LU1969619763.USD","BK0077","LU2328871848.SGD","BK1574"],"gpt_icon":0}],"pageSize":20,"totalPage":23,"pageCount":1,"totalSize":446,"code":"91000000","status":"200"}]}}